By bgilgerNew publication out today in Scientific Reports from the Gilger & Hirsch laboratories demonstrating the potential of AAV-HLA-G gene therapy for immune suppression, reduction of... |Uncategorized
By bgilgerFortress Biosciences announced today that they are forming Tambid Bio, a new company to develop IP generated and licensed from Dr. Gilger’s (NCSU) and Dr....
